Department of Anesthesiology and Intensive Care, Rangueil Hospital-University Hospital of Toulouse, 1 Avenue du Professeur Jean Poulhès TSA 50032, 31059, Toulouse Cedex 9, France.
Institute of Metabolic and Cardiovascular Diseases, INSERM/UPS UMR, 1048-I2MC, Equipe 3, Paul Sabatier University, Toulouse, France.
J Transl Med. 2020 Apr 19;18(1):174. doi: 10.1186/s12967-020-02342-8.
In sepsis, the endothelial barrier becomes incompetent, with the leaking of plasma into interstitial tissues. VE-cadherin, an adherens junction protein, is the gatekeeper of endothelial cohesion. Kinins, released during sepsis, induce vascular leakage and vasodilation. They act via two G-protein coupled receptors: B1 (B1R) and B2 (B2R). B1R is inducible in the presence of pro-inflammatory cytokines, endotoxins or after tissue injury. It acts at a later stage of sepsis and elicits a sustained inflammatory response. The aim of our study was to investigate the relationships between B1R and VE-cadherin destabilization in vivo in a later phase of sepsis.
Experimental, prospective study in a university research laboratory. We used a polymicrobial model of septic shock by cecal ligation and puncture in C57BL6 male mice or C57BL6 male mice that received a specific B1R antagonist (R-954). We studied the influence of B1R on sepsis-induced vascular permeability 30 h after surgery for several organs, and VE-cadherin expression in the lung and kidneys by injecting R-954 just before surgery. The 96-h survival was determined in mice without treatment or in animals receiving R-954 as a "prophylactic" regimen (a subcutaneous injection of 200 µg/kg, prior to CLP and 24 h after CLP), or as a "curative" regimen (injection of 100 µg/kg at H6, H24 and H48 post-surgery).
B1R inactivation helps to maintain MAP above 65 mmHg but induces different permeability profiles depending on whether or not organ perfusion is autoregulated. In our model, VE-cadherin was destabilized in vivo during septic shock. At a late stage of sepsis, the B1R blockade reduced the VE-cadherin disruption by limiting eNOS activation. The survival rate for mice that received R-954 after sepsis induction was higher than in animals that received an antagonist as a prophylactic treatment.
B1R antagonizing reduced mortality in our model of murine septic shock by limiting the vascular permeability induced by VE-cadherin destabilization through maintenance of the macrohemodynamics, consequently limiting organ dysfunctions.
在脓毒症中,内皮屏障变得不健全,血浆渗漏到间质组织中。VE-钙黏蛋白是一种黏附连接蛋白,是内皮细胞黏附的守门员。激肽在脓毒症期间释放,诱导血管渗漏和血管扩张。它们通过两种 G 蛋白偶联受体发挥作用:B1(B1R)和 B2(B2R)。B1R 在存在促炎细胞因子、内毒素或组织损伤时可诱导。它在脓毒症的后期阶段起作用,并引发持续的炎症反应。我们的研究目的是在脓毒症后期阶段体内研究 B1R 与 VE-钙黏蛋白失稳之间的关系。
在大学研究实验室进行实验性、前瞻性研究。我们使用盲肠结扎和穿刺术建立多微生物脓毒性休克模型,在 C57BL6 雄性小鼠或接受特定 B1R 拮抗剂(R-954)的 C57BL6 雄性小鼠中进行。我们研究了 B1R 对手术后 30 小时几个器官的脓毒症诱导的血管通透性的影响,以及肺和肾脏中 VE-钙黏蛋白的表达,方法是在手术前注射 R-954。未治疗的小鼠或接受 R-954 作为“预防”方案(CLP 前和 CLP 后 24 小时皮下注射 200μg/kg)或作为“治疗”方案(手术后 6、24 和 48 小时注射 100μg/kg)的动物的 96 小时存活率。
B1R 失活有助于将 MAP 维持在 65mmHg 以上,但会根据器官灌注是否自动调节而导致不同的通透性特征。在我们的模型中,VE-钙黏蛋白在脓毒性休克期间在体内失稳。在脓毒症后期,B1R 阻断通过限制 eNOS 激活来减少 VE-钙黏蛋白的破坏。在诱导脓毒症后接受 R-954 的小鼠的存活率高于接受拮抗剂作为预防治疗的动物。
在我们的脓毒性休克小鼠模型中,B1R 拮抗剂通过维持宏观血液动力学来限制 VE-钙黏蛋白失稳诱导的血管通透性,从而限制器官功能障碍,降低死亡率。